ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

InnoCare Pharma Limited clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 67 studies whose lead sponsor is InnoCare Pharma Limited or one of 2 companies grouped under it. 39 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 13, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Compare InnoCare Pharma with AbbVie and Eli Lilly →

Pipeline: 10 programs

Each counted once: 10 with a study InnoCare Pharma Limited leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 3 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of InnoCare Pharma Limited’s own registered studies; InnoCare Pharma Limited’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

One of InnoCare Pharma’s programs has a dated deal behind it: 1 licensed out. Each from the companies’ own releases and filings, linked; the registry does not record them.

Licensed out 1

What it is testing

The drugs InnoCare Pharma Limited’s studies test, most open studies first — 9 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

7 of InnoCare Pharma Limited’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 1D
  3. J’27
  4. F
  5. 2M
  6. A
  7. M
  8. 2J
  9. J
  10. A
  11. 1S
  12. O
  13. N

Add all 7 to your calendar (.ics) → With an account.

All 67 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now3958%Recruiting 31 · Not yet recruiting 8
  • Under way, not recruiting46%
  • Completed1522%
  • Status unknown or other913%

Phase

Where

  • China60
  • United States8
  • Australia3
  • Ukraine3
  • Poland3
  • Germany1

Over the years

  1. 17
  2. 18
  3. 19
  4. 20
  5. 1021
  6. 22
  7. 23
  8. 24
  9. 25
  10. 1026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to InnoCare Pharma Limited.

  • Beijing InnoCare Pharma Tech Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    61 studies →
  • InnoCare Pharma Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies
  • Innocare Pharma Australia Pty Ltd
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 50 of 67. Browse all 67 →